A new and convenient synthesis of 1-benzyl-1-azaspiro [5.5] undecan-7-one: A formal synthesis of (±)-perhydrohistrio-nicotoxin

Article abstract of DOI:10.1080/00397919508011440

A rapid, three-step synthesis of the title compound 3 in 40% overall yield from (±)-pipecolinic acid, is described.

Full text of DOI:10.1080/00397919508011440

This article was downloaded by: [North Carolina State University]
On: 20 January 2013, At: 08:37
Publisher: Taylor & Francis
Informa Ltd Registered in England and Wales Registered Number: 1072954
Registered office: Mortimer House, 37-41 Mortimer Street, London W1T 3JH,
UK
Synthetic Communications: An
International Journal for Rapid
Communication of Synthetic
Organic Chemistry
Publication details, including instructions for
authors and subscription information:
http://www.tandfonline.com/loi/lsyc20
A New and Convenient
Synthesis of 1-Benzyl-1-
azaspiro [5.5]-undecan-7-
one: A Formal Synthesis of (±)-
Perhydrohistrio-nicotoxin
Philippe Compain a , Jacques Goré a & Jean-Michel
Vatéle a
a Laboratoire de Chimie Organique 1, Université
Claude Bernard, B[acaron]t. 308 43 Bd du 11
Novembre 1918, 69622, Villeurbanne Cédex, France
Version of record first published: 16 Feb 2007.
To cite this article: Philippe Compain , Jacques Goré & Jean-Michel Vatéle (1995):
A New and Convenient Synthesis of 1-Benzyl-1-azaspiro [5.5]-undecan-7-one: A
Formal Synthesis of (±)-Perhydrohistrio-nicotoxin, Synthetic Communications: An
International Journal for Rapid Communication of Synthetic Organic Chemistry, 25:19,
3075-3080
To link to this article: http://dx.doi.org/10.1080/00397919508011440
PLEASE SCROLL DOWN FOR ARTICLE
Full terms and conditions of use: http://www.tandfonline.com/page/terms-
and-conditions

This article may be used for research, teaching, and private study purposes.
Any substantial or systematic reproduction, redistribution, reselling, loan,
sub-licensing, systematic supply, or distribution in any form to anyone is
expressly forbidden.
The publisher does not give any warranty express or implied or make any
representation that the contents will be complete or accurate or up to
date. The accuracy of any instructions, formulae, and drug doses should be
independently verified with primary sources. The publisher shall not be liable
for any loss, actions, claims, proceedings, demand, or costs or damages
whatsoever or howsoever caused arising directly or indirectly in connection
with or arising out of the use of this material.